Encare Selected for Health3-2-1 to Drive Expansion into the U.S. Market
Encare is proud to announce that it has been selected as one of the few Swedish companies to participate in Health3-2-1, an EU-funded initiative designed to accelerate international expansion for leading life science companies. As part of this initiative, Encare will focus on strengthening its presence in the U.S., a key market for innovative healthcare solutions.“We are honored to be selected for Health 3-2-1 and see tremendous potential in the U.S. market,” says Rasmus Waller, CEO of Encare. “With the growing emphasis on surgical quality improvement and enhanced recovery protocols, we